Melatonin protects cardiac microvasculature against ischemia/reperfusion injury via suppression of mitochondrial fission-VDAC1-HK2-mPTP-mitophagy axis.

Zhou H, Zhou H, Zhang Y, Hu S, Shi C, Zhu P, Ma Q, Jin Q, Cao F, Tian F, Chen Y. · 2017

Read Melatonin protects cardiac microvasculature against ischemia/reperfusion injury via suppression of mitochondrial fission-VDAC1-HK2-mPTP-mitophagy axis. by Zhou H, Zhou H, Zhang Y, Hu S, Shi C, Zhu P, Ma Q, Jin Q, Cao F, Tian F, Chen Y. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5518188.txt.

Introduction

Zhou and co-authors report a mouse study in the Journal of Pineal Research on melatonin and heart injury. Reopening a blocked heart artery can itself harm the tiny vessels downstream. About 30 percent of heart attack patients suffer this added injury. Few treatments target it directly. The team tested whether melatonin shields those small vessels.

Treated mice kept better blood flow and heart function, they report. The vessel lining stayed intact with less cell death. Melatonin calmed excess splitting of mitochondria inside vessel cells. That pause blocked a chain ending in cell self-eating and death. Mice lacking the energy sensor AMPK lost the benefit entirely.

Catalog record

CREATORZhou H, Zhou H, Zhang Y, Hu S, Shi C, Zhu P, Ma Q, Jin Q, Cao F, Tian F, Chen Y.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE50 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5518188

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Melatonin protects cardiac microvasculature against ischemia/reperfusion injury via suppression of mitochondrial fission‐VDAC1‐HK2‐mPTP‐mitophagy axis By Hao Zhou, Ying Zhang, Shunying Hu, Chen Shi, Pingjun Zhu, Qiang Ma, Qinhua Jin, Feng Cao, Feng Tian, Yundai Chen Published in: Journal of Pineal Research DOI: 10.1111/jpi.12413 ABSTRACT Abstract The cardiac microvascular system, which is primarily composed of monolayer endothelial cells, is the site of blood supply and nutrient exchange to cardiomyocytes. However, microvascular ischemia/reperfusion injury (IRI) following percutaneous coronary intervention is a woefully neglected topic, and few strategies are available to reverse such pathologies. Here, we studied the effects of melatonin on microcirculation IRI and elucidated the underlying mechanism. Melatonin markedly reduced infarcted area, improved cardiac function, restored blood flow, and lower microcirculation perfusion defects. Histological analysis showed that cardiac microcirculation endothelial cells (CMEC) in melatonin‐treated mice had an unbroken endothelial barrier, increased endothelial nitric oxide synthase expression, unobstructed lumen, reduced inflammatory cell infiltration, and less endothelial damage. In contrast, AMP‐activated protein kinase α (AMPKα) deficiency abolished the beneficial effects of melatonin on microvasculature. In vitro, IRI activated dynamin‐related protein 1 (Drp1)‐dependent mitochondrial fission, which subsequently induced voltage‐dependent anion channel 1 (VDAC1) oligomerization, hexokinase 2 (HK2) liberation, mitochondrial permeability transition pore (mPTP) opening, PINK1/Parkin upregulation, and ultimately mitophagy‐mediated CMEC death. However, melatonin strengthened CMEC survival via activation of AMPKα, followed by p‐Drp1S616 downregulation and p‐Drp1S37 upregulation, which blunted Drp1‐dependent mitochondrial fission. Suppression of mitochondrial fission by melatonin recovered VDAC1‐HK2 interaction that prevented mPTP opening and PINK1/Parkin activation, eventually blocking mitophagy‐mediated cellular death. In summary, this study confirmed that melatonin protects cardiac microvasculature against IRI. The underlying mechanism may be attributed to the inhibitory effects of melatonin on mitochondrial fission‐VDAC1‐HK2‐mPTP‐mitophagy axis via activation of AMPKα. Keywords: AMP‐activated protein kinase α, cardiac microcirculation endothelial cells, hexokinase 22, melatonin, microvascular IR injury, mitochondrial fission, mitochondrial permeability transition pore opening, voltage‐dependent anion channel 1 INTRODUCTION Despite the successful revascularization of occluded epicardial vessels, the postischemia failure of reperfusion to the microvascular bed termed as microcirculatory ischemia/reperfusion injury (IRI)1 occurs in approximately 30% of patients with acute myocardial infarction (AMI).2 The cardiac microvascular IRI is primarily caused by cardiac microcirculation endothelial cell (CMEC) apoptosis which induces endothelial swelling, microvascular spasms, and capillary obstruction and slows or stops microcirculation blood flow3 following the restoration of the epicardial blood flow, leading to additional myocardial damage and increased 30‐day mortality rates.4 These evidences suggest vasculature IRI reduces the effectiveness of reperfusion therapy and compromising the clinical benefits of patients with AMI,5 and therefore, strategies to protect cardiac microvascular against IRI and maintain their normal function may represent crucial adjuvant modalities for patients with AMI. Evidence has accumulated for the protective actions of physiological concentrations of melatonin on microcirculation via maintaining the endothelial barrier function,6 preserving endothelial permeability,7 reducing cellular excessive oxidative stress,8 and alleviating endothelial‐dependent NO overproduction.9 However, the role of melatonin in cardiac microvascular damage is far from clear. Recently, mitochondrial homeostasis has emerged as the key regulator of cell death regarding to cardiac IRI, especially mitochondrial fission and mitophagy.10, 11 Excessive mitochondrial fission aggravates cardiac IRI via alternating the balance of pro‐ and antisurvival factors. In addition to mitochondrial fission, cells are capable to selectively remove several dysfunctional mitochondria from the integrated network to maintain organelle quality and homeostasis via an autophagy‐related process, termed mitophagy.12 An excessive shift toward mitophagy consumes most of mitochondria, leading to energy shortage and subsequent cellular death in cardiomyocytes. What remains unclear is whether mitochondrial fission and mitophagy are the trigger of cardiac microvascular IRI and CMEC death and, if so, whether melatonin is capable of alleviating cardiac microcirculatory damage by regulating mitochondrial fission and mitophagy. AMP‐activated protein kinase signaling (AMPK) acts as an intracellular energy sensor. Previous study has found that melatonin was the trigger of AMPK pathways.13 Furthermore, activated AMPK by melatonin protects mitochondrial respiration.14 Recent studies suggested that activation of AMPK could repress mitochondrial fission via inactivation of dynamin‐related protein 1 (Drp1)15 and other studies indicated that AMPK could also handle mitophagy.16 However, whether melatonin protects cardiac microvascular against IRI through modulation of excessive mitochondrial fission and mitophagy by activation of AMPK remains unknown. To solve this problem, we generated AMPKα−/− mice (AMPKα is the major isoform in endothelial cells17) to observe the protective effects of melatonin on mitochondria. The results suggested that melatonin protected cardiac vasculature against IRI in an AMPKα‐dependent manner. Activation of AMPKα by melatonin blunted mitochondrial fission, which prevented voltage‐dependent anion channel 1 (VDAC1) and hexokinase 2 (HK2) disassociation, mitochondrial permeability transition pore (mPTP) opening and excessive mitophagy, contributing to CMEC survival in response to IRI. Furthermore, more CMEC survival via melatonin treatment by activation of AMPKα improved the endothelial barrier function, reduced inflammatory cell infiltration, preserved e‐NOS contents, restored blood flow, limited infarcted area, and ultimately reduced cardiac microvasculature IRI. MATERIAL AND METHODS Animal models of cardiac IRI 2.1. This study was conducted in accordance with the Declaration of Helsinki and the guidelines of the Ethics Committee of Chinese PLA (People's Liberty Army) General Hospital, Beijing, China. All experimental protocols were approved by Ethics Committee of Chinese PLA (People's Liberty Army) General Hospital, Beijing, China. AMPKα−/− mice with a C57BL/6 background were generated as previously described.15 AMPKα−/− and wild‐type (WT) male mice (8‐wk‐old, 20‐25 g) were used to induce IRI model. For induction of IRI, a 7‐0 silk suture was subsequently passed underneath the left anterior descending coronary artery, and a slipknot was tied with 30 minutes of ischemia followed by 2‐h reperfusion. The melatonin (Sigma‐Aldrich, St. Louis, MO, USA) was administered (20 mg/kg) intraperitoneally 12 hours before IRI according to our previous study.18 Melatonin was initially dissolved in ethanol and then diluted in sterile water (final concentration of ethanol <1%). At the end of the reperfusion period, the hearts were stained with 2% Evans blue and 1% TTC. The infarct size was expressed as percentage of the total left ventricular (LV) area (n=6/group). CMEC culture and IRI induction in vitro 2.2. CMECs were isolated from the hearts of AMPKα−/− and WT male mice using the enzyme dissociation method as described by our previous study.19 The purity of the cultured cells was assessed by CD31 staining and uptake of acetylated low‐density lipoprotein (Fig. S1A‐B). In vitro, CMECs obtained from WT and AMPKα−/− mice, respectively. As shown in Fig. S2, melatonin could activate AMPKα at Thr172 in WT‐CMECs but not in AMPKα−/− ‐CMECs. Meanwhile, AMPKα gain‐of‐function experiment was performed by AMPKα adenovirus vector (Ad) overexpression in CMECs isolated from AMPKα−/− mice (Ad+AMPKα−/−). For melatonin pretreatment, 5 μmol L−1 melatonin18 was used 12 hours before IRI in WT‐CMECs, AMPKα−/−‐CMECs and Ad+AMPKα−/−‐CMECs, which were named Mel+WT group, Mel+AMPKα−/− group, and Ad+Mel+AMPKα−/− group, respectively. The same volume of PBS was used in WT‐CMECs 12 hours before IRI, which was named WT group. The IRI in vitro was mimicked by 30 minutes of hypoxia with serum starvation and 2 hours of reoxygeneration.19 Hypoxic conditions used fresh Hanks solution with 95% N2 and 5% CO2. The pH was adjusted to 6.8 with lactate to mimic ischemic conditions. Echocardiogram and myocardial contrast echocardiography (MCE) 2.3. Echocardiography was performed after 2‐h reperfusion by echocardiogram (14.0 MHz, Sequoia C512; Acuson, Germany). Myocardial contrast echocardiography (MCE) was performed using a 14‐MHz linear transducer (Acuson Sequoia C512 system)

Read the complete text